Baker Bros. Advisors’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$64M	Hold	5,072,730	–	–	0.37%	34
2025 Q4	$52.1M	Buy	5,072,730 +206,911	+4%	+$1.74M	0.31%	37
2025 Q3	$28.2M	Hold	4,865,819	–	–	0.2%	41
2025 Q2	$32.7M	Hold	4,865,819	–	–	0.32%	30
2025 Q1	$44M	Hold	4,865,819	–	–	0.49%	24
2024 Q4	$84.1M	Hold	4,865,819	–	–	0.9%	16
2024 Q3	$77.8M	Hold	4,865,819	–	–	0.81%	18
2024 Q2	$69.3M	Hold	4,865,819	–	–	0.89%	19
2024 Q1	$68.9M	Hold	4,865,819	–	–	0.86%	16
2023 Q4	$73.4M	Hold	4,865,819	–	–	0.84%	14
2023 Q3	$76.9M	Hold	4,865,819	–	–	0.44%	15
2023 Q2	$73.7M	Hold	4,865,819	–	–	0.43%	19
2023 Q1	$70.6M	Hold	4,865,819	–	–	0.38%	17
2022 Q4	$65.8M	Hold	4,865,819	–	–	0.4%	19
2022 Q3	$76.7M	Hold	4,865,819	–	–	0.5%	19
2022 Q2	$59.3M	Buy	4,865,819 +161,400	+3%	+$1.22M	0.34%	19
2022 Q1	$44.2M	Hold	4,704,419	–	–	0.25%	31
2021 Q4	$80.5M	Buy	+4,704,419	New	+$114M	0.39%	23